Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

FB Medizin, Universitätsklinikum Essen, Klinik für Hämatologie und Stammzelltransplantation

Anschrift
Hufelandstraße 55
45147 Essen
Telefon
Telefax

Funktionen

  • , Klinik für Hämatologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Ferrández, Maria C.; Golla, Sandeep S. V.; Eertink, Jakoba J.; de Vries, Bart M.; Lugtenburg, Pieternella J.; Wiegers, Sanne E.; Zwezerijnen, Gerben J. C.; Pieplenbosch, Simone; Kurch, Lars; Hüttmann, Andreas; Hanoun, Christine; Dührsen, Ulrich; de Vet, Henrica C. W.; Josée M., Zijlstra; Ronald, Boellaard; PETRA
    An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
    In: Scientific Reports Jg. 13 (2023) Nr. 1, 13111
  • Eertink, J.J.; Zwezerijnen, G.J.C.; Heymans, M.W.; Pieplenbosch, S.; Wiegers, S.E.; Dührsen, U.; Hüttmann, Andreas; Kurch, L.; Hanoun, C.; Lugtenburg, P.J.; Barrington, S.F.; Mikhaeel, N.G.; Ceriani, L.; Zucca, E.; Czibor, S.; Györke, T.; Chamuleau, M.E.D.; Hoekstra, O.S.; de Vet, H.C.W.; Boellaard, R.; Zijlstra, J.M.; Eertink, Jakoba Johanna; Zwezerijnen, Gerben JC; Heymans, Martijn; Wiegers, Sanne Elisabeth; Lugtenburg, Pieternella J.; Barrington, Sally; Mikhaeel, N. George; Chamuleau, Martine E.D.; Hoekstra, Otto S; De Vet, Henrica CW; Zijlstra, Josée M.
    Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
    In: Blood Jg. 141 (2023) Nr. 25, S. 3055 - 3064
  • Zwezerijnen, Gerben J.C.; Wiegers, Sanne E.; Pieplenbosch, Simone; Chamuleau, Martine E.D.; Lugtenburg, Pieternella J.; de Jong, Daphne; Ylstra, Bauke; Mendeville, Matias; Dührsen, Ulrich; Hanoun, Christine; Hüttmann, Andreas; Richter, Julia; Klapper, Wolfram; Jauw, Yvonne W.S.; Hoekstra, Otto S.; de Vet, Henrica C.W.; Boellaard, Ronald; Zijlstra, Josée M.; Eertink, Jakoba Johanna; Eertink, Jakoba Johanna
    Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
    In: Blood Advances Jg. 7 (2023) Nr. 2, S. 214 - 223
  • Sworder, Brian J.; Kurtz, David M.; Alig, Stefan K.; Frank, Matthew J.; Shukla, Navika; Garofalo, Andrea; Macaulay, Charles W.; Shahrokh Esfahani, Mohammad; Olsen, Mari N.; Hamilton, James; Hosoya, Hitomi; Hamilton, Mark; Spiegel, Jay Y.; Baird, John H.; Sugio, Takeshi; Carleton, Mia; Craig, Alexander F.M.; Younes, Sheren F.; Sahaf, Bita; Sheybani, Natasha D.; Schroers-Martin, Joseph G.; Liu, Chih Long; Oak, Jean S.; Jin, Michael C.; Beygi, Sara; Hüttmann, Andreas; Hanoun, Christine; Dührsen, Ulrich; Westin, Jason R.; Khodadoust, Michael S.; Natkunam, Yasodha; Majzner, Robbie G.; Mackall, Crystal L.; Diehn, Maximilian; Miklos, David B.; Alizadeh, Ash A.
    Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
    In: Cancer Cell Jg. 41 (2023) Nr. 1, S. 210 - 225.e5
  • Hoffmann, Christian; Ringbaek, Toke; Eckstein, Anja; Deya, Wolfgang; Santiago, Alina; Heintz, Martin; Lübcke, Wolfgang; Indenkämpen, Frank; Sauerwein, Wolfgang; Flühs, Andrea; Le Guin, Claudia; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia; Deuschl, Cornelius; Moliavi, Sourour; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Johansson, Patricia; Bechrakis, Nikolaos; Stuschke, Martin; Guberina, Maja
    Long-Term Follow-Up of Patients with Conjunctival Lymphoma after Individualized Lens-Sparing Electron Radiotherapy : Results from a Longitudinal Study
    In: Cancers Jg. 15 (2023) Nr. 22, 5433
  • Hoffmann, Christian; Mohr, Christopher; Johansson, Patricia; Eckstein, Anja; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia Luise; Deuschl, Cornelius; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Moliavi, Sourour; Bechrakis, Nikolaos; Stuschke, Martin; Guberina, Maja
    MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy : imaging remission criteria and volumetric regression kinetics
    In: Scientific Reports Jg. 13 (2023) Nr. 1, 4792
  • Friese, Christina; Breuckmann, Katharina; Hüttmann, Andreas; Eisele, Lewin; Dührsen, Ulrich
    Neutropenia-related aspergillosis in non-transplant haematological patients hospitalised under ambient air versus purified air conditions
    In: Mycoses Jg. 66 (2023) Nr. 6, S. 505 - 514
  • Johansson, Patricia; Alig, Stefan; Richter, Julia; Hanoun, Christine; Rekowski, Jan; Dürig, Jan; Ylstra, Bauke; de Jong, Daphne; Klapper, Wolfram; Alizadeh, Ash A.; Dührsen, Ulrich; Hüttmann, Andreas
    Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma
    In: Annals of Hematology Jg. 102 (2023) Nr. 12, S. 3445 - 3455
  • Fischer, Luca; Jiang, Linmiao; Bittenbring, Joerg Thomas; Huebel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Juergen; Glass, Bertram; Hüttmann, Andreas; Schaefer-Eckart, Kerstin; Silkenstedt, Elisabeth; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin; Hoster, Eva
    The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma : A pooled trials analysis
    In: Annals of Hematology Jg. 102 (2023) Nr. 10, S. 2791 - 2801
  • Hess, Georg; Hüttmann, Andreas; Witzens‐Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias; Lenz, Georg
    A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma : Final results of the prospective, multicentre GOAL trial
    In: British Journal of Haematology Jg. 198 (2022) Nr. 3, S. 482 - 491
  • Thieblemont, Catherine; Chartier, Loic; Dührsen, Ulrich; Vitolo, Umberto; Barrington, Sally F.; Zaucha, Jan M.; Vercellino, Laetitia; Silva, Maria Gomes; Patrocinio-Carvalho, Ines; Decazes, Pierre; Viailly, Pierre-Julien; Tilly, Herve; Berriolo-Riedinger, Alina; Casasnovas, Oliver; Hüttmann, Andreas; Ilyas, Hajira; Mikhaeel, N. George; Dunn, Joel; Cottereau, Anne-Ségoléne; Schmitz, Christine; Kostakoglu, Lale; Paulson, Joseph N.; Nielsen, Tina; Meignan, Michael
    A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
    In: Blood Advances Jg. 6 (2022) Nr. 23, S. 5995 - 6004
  • Sasse, Stephanie; Bröckelmann, Paul Jan; Momotow, Jesko; Plütschow, Annette; Hüttmann, Andreas; Basara, Nadezda; Koenecke, Christian; Martin, Sonja; Bentz, Martin; Grosse-Thie, Christina; Thorspecken, Sven; de Wit, Maike; Kobe, Carsten; Dietlein, Markus; von Tresckow, Bastian; Fuchs, Michael; Borchmann, Peter; Engert, Andreas
    AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma : final results of an open-label, randomized, multicenter phase II trial
    In: Leukemia and Lymphoma (2022)
  • Greuter, M.J.E.; Eertink, J.J.; Jongeneel, G.; Dührsen, U.; Hüttmann, Andreas; Schmitz, C.; Lugtenburg, P.J.; Barrington, S.F.; Mikhaeel, N.G.; Ceriani, L.; Zucca, E.; Carr, R.; Györke, T.; Burggraaff, C.N.; de Vet, H.C.W.; Hoekstra, O.S.; Zijlstra, J.M.; Coupé, V.M.H.
    Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma
    In: Clinical Lymphoma, Myeloma & Leukemia Jg. 22 (2022) Nr. 6, S. 382 - 392
  • Koch, Karoline; Richter, Julia; Hanel, Christoph; Hüttmann, Andreas; Dührsen, Ulrich; Klapper, Wolfram
    Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation
    In: Haematologica / The Hematology Journal Jg. 107 (2022) Nr. 9, S. 2144 - 2153
  • Denker, Sophy; Bittner, Aitomi; Frick, Mareike; Kase, Julia; Hoffmann, Jörg; Trenker, Corinna; Keller, Ulrich; Bogner, Christian; Hüttmann, Andreas; Dürig, Jan; Janz, Martin; Mathas, Stephan; Marks, Reinhard; Krohn, Ulrike; Na, Il-Kang; Bullinger, Lars; Schmitt, Clemens A.
    Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma : First analysis of toxicity and efficacy signals
    In: Leukemia and Lymphoma Jg. 63 (2022) Nr. 1, S. 84 - 92
  • Bröcker-Preuß, Martina; Becher-Boveleth, Nina; Müller, Stefan P.; Hüttmann, Andreas; Hanoun, Christine; Grafe, Hong; Richter, Julia; Klapper, Wolfram; Rekowski, Jan; Bockisch, Andreas; Dührsen, Ulrich
    Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma : Results from the PETAL trial
    In: Journal of Cancer Research and Clinical Oncology Jg. 148 (2022) Nr. 10, S. 2611 - 2621
  • Jacob, Anne Sophie; Kaul, Helen; Fuchs, Michael; Gillessen, Sarah; Kreissl, Stefanie; Pluetschow, Annette; Momotow, Jesko; Schaub, Valdete; Hüttmann, Andreas; Haenel, Mathias; Zimmermann, Andreas; Dierlamm, Judith; Meissner, Julia; Mathas, Stephan; Martin, Sonja; Engert, Andreas; Hallek, Michael; Borchmann, Peter; Lehmann, Clara
    Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma
    In: Infection - A Journal of Infectious Disease Jg. 50 (2022) Nr. 4, S. 925 - 932
  • Seifert, Robert; Kersting, David; Rischpler, Christoph; Sandach, Patrick; Ferdinandus, Justin; Fendler, Wolfgang; Rahbar, Kambiz; Weckesser, Matthias; Umutlu, Lale; Hanoun, Christine; Hüttmann, Andreas; Reinhardt, Hans Christian; von Tresckow, Bastian; Herrmann, Ken; Dührsen, Ulrich; Schäfers, Michael
    Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trial
    In: Leukemia Jg. 36 (2022) Nr. 12, S. 2845 - 2852
  • Hoffmann, Christian; Rating, Philipp; Bechrakis, Nikolaos; Eckstein, Anja; Sokolenko, Ekaterina; Jabbarli, Leyla; Westekemper, Henrike; Mohr, Christopher; Schmeling, Claus; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia Luise; Deuschl, Cornelius; Johansson, Patricia; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Moliavi, Sourour; Stuschke, Martin; Guberina, Maja
    Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy : Results from a longitudinal study
    In: Hematological Oncology Jg. 40 (2022) Nr. 5, S. 922 - 929
  • Kadow, Stephanie; Schumacher, Fabian; Kramer, Melanie; Hessler, Gabriele; Scholtysik, René; Oubari, Sara; Johansson, Patricia; Hüttmann, Andreas; Reinhardt, Hans Christian; Kleuser, Burkhard; Zoratti, Mario; Mattarei, Andrea; Szabò, Ildiko; Gulbins, Erich; Carpinteiro, Alexander
    Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma
    In: Cancers Jg. 14 (2022) Nr. 8, 1955
  • Momotow, Jesko; Bühnen, Ina; Trautmann-Grill, Karolin; Kobbe, Guido; Hahn, Dennis; Schroers, Roland; Heinrich, Bernhard; Gaska, Tobias; Forstbauer, Helmut; Schmidt, Burkhard; Boger, Regina; Hüttmann, Andreas; Heil, Gerhard; Kraemer, Doris M.; Krüger, William; Zeremski, Vanja; Grobe, Norbert; Jentsch-Ullrich, Kathleen; Griesinger, Frank; Fuchs, Michael; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas; Bröckelmann, Paul J.
    Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma : A German Hodgkin Study Group multicentre real-world analysis
    In: British Journal of Haematology Jg. 198 (2022) Nr. 2, S. 401 - 404
  • Mikhaeel, N George; Heymans, Martijn W.; Eertink, Jakoba J.; de Vet, Henrica C W; Boellaard, Ronald; Dührsen, Ulrich; Ceriani, Luca; Schmitz, Christine; Wiegers, Sanne E.; Hüttmann, Andreas; Lugtenburg, Pieternella J.; Zucca, Emanuele; Zwezerijnen, Gerben J C; Hoekstra, Otto S.; Zijlstra, Josée M; Barrington, Sally F.
    Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma : International Metabolic Prognostic Index
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 21, S. 2352 - 2360
  • Gillessen, Sarah; Hüttmann, Andreas; Vucinic, Vladan; Müller, Horst; Plütschow, Annette; Viardot, Andreas; Topp, Max S.; Kobe, Carsten; Böll, Boris; Eichenauer, Dennis A.; Sasse, Stephanie; Haverkamp, Heinz; Schmitz, Christine; Borchmann, Sven; Bröckelmann, Paul J.; Heger, Jan-Michel; Fuchs, Michael; Engert, Andreas; Borchmann, Peter; von Tresckow, Bastian
    Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma : An experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)
    In: British Journal of Haematology Jg. 196 (2022) Nr. 3, S. 606 - 616
  • Bachy, Emmanuel; Camus, Vincent; Thieblemont, Catherine; Sibon, David; Casasnovas, René-Olivier; Ysebaert, Loïc; Damaj, Gandhi; Guidez, Stéphanie; Pica, Gian Matteo; Kim, Won Seog; Lim, Soon Thye; André, Marc; García-Sancho, Alejandro Martín; Penarrubia, Maria Jesus; Staber, Philipp B.; Trotman, Judith; Hüttmann, Andreas; Stefoni, Vittorio; Re, Alessandro; Gaulard, Philippe; Delfau-Larue, Marie-Helene; de Leval, Laurence; Meignan, Michel; Li, Ju; Morschhauser, Franck; Delarue, Richard
    Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma : Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 3, S. 242 - 251
  • Horwitz, S.; O'Connor, O.A.; Pro, B.; Trümper, L.; Iyer, S.; Advani, R.; Bartlett, N.L.; Christensen, J.H.; Morschhauser, F.; Domingo-Domenech, E.; Rossi, G.; Kim, W.S.; Feldman, T.; Menne, T.; Belada, D.; Illés, Á.; Tobinai, K.; Tsukasaki, K.; Yeh, S.-P.; Shustov, A.; Hüttmann, Andreas; Savage, K.J.; Yuen, S.; Zinzani, P.L.; Miao, H.; Bunn, V.; Fenton, K.; Fanale, M.; Puhlmann, M.; Illidge, T.
    The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
    In: Annals of Oncology Jg. 33 (2022) Nr. 3, S. 288 - 298
  • Kurtz, David M.; Soo, Joanne; Co Ting Keh, Lyron; Alig, Stefan; Chabon, Jacob J.; Sworder, Brian J.; Schultz, Andre; Jin, Michael C.; Scherer, Florian; Garofalo, Andrea; Macaulay, Charles W.; Hamilton, Emily G.; Chen, Binbin; Olsen, Mari; Schroers-Martin, Joseph G.; Craig, Alexander F. M.; Moding, Everett J.; Esfahani, Mohammad S.; Liu, Chih Long; Dührsen, Ulrich; Hüttmann, Andreas; Casasnovas, René-Olivier; Westin, Jason R.; Roschewski, Mark; Wilson, Wyndham H.; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
    In: Nature Biotechnology Jg. 39 (2021) Nr. 12, S. 1537 - 1547
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trials
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 11, S. 3550 - 3559
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trials
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 11, S. 3550 - 3559
  • Rekowski, Jan; Hüttmann, Andreas; Schmitz, Christine; Müller, Stefan P.; Kurch, Lars; Kotzerke, Jörg; Franzius, Christiane; Weckesser, Matthias; Bengel, Frank M.; Freesmeyer, Martin; Hertel, Andreas; Krohn, Thomas; Holzinger, Jens; Brink, Ingo; Haberkorn, Uwe; Nyuyki, Fonyuy; van Assema, Daniëlle M E; Geworski, Lilli; Hasenclever, Dirk; Jöckel, Karl-Heinz; Dührsen, Ulrich
    Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations : Comparison of the Deauville 5-Point Scale and the ΔSUVmₐₓ Method
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 1, S. 37 - 42
  • Kurch, Lars; Hüttmann, Andreas; Georgi, Thomas W.; Rekowski, Jan; Sabri, Osama; Schmitz, Christine; Kluge, Regine; Dührsen, Ulrich; Hasenclever, Dirk
    Interim PET in Diffuse Large B-Cell Lymphoma
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 8, S. 1068 - 1074
  • Eertink, J. J.; Burggraaff, C. N.; Heymans, M. W.; Dührsen, Ulrich; Hüttmann, Andreas; Schmitz, Christine; Müller, S.; Lugtenburg, P. J.; Barrington, S. F.; Mikhaeel, N. G.; Carr, R.; Czibor, S.; Györke, T.; Ceriani, L.; Zucca, E.; Hutchings, M.; Kostakoglu, L.; Loft, A.; Fanti, S.; Wiegers, S. E.; Pieplenbosch, S.; Boellaard, R.; Hoekstra, O. S.; Zijlstra, J. M.; de Vet, H. C. W.
    Optimal timing and criteria of interim PET in DLBCL : a comparative study of 1692 patients
    In: Blood Advances Jg. 5 (2021) Nr. 9, S. 2375 - 2384
  • Borchmann, Peter; Plütschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sökler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Hüttmann, Andreas; Wilhelm, Martin; Zijlstra, Josée M; Moccia, Alden; Kuhnert, Georg; Bröckelmann, Paul J; von Tresckow, Bastian; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas
    PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology Jg. 22 (2021) Nr. 2, S. 223 - 234
  • Dührsen, Ulrich; Tometten, Mareike; Kroschinsky, Frank; Ganser, Arnold; Ibach, Stefan; Bertram, Stefanie; Hüttmann, Andreas
    Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma
    In: Blood Cancer Journal Jg. 11 (2021) Nr. 5, 95
  • Liebers, Nora; Duell, Johannes; Fitzgerald, Donnacha; Kerkhoff, Andrea; Noerenberg, Daniel; Kaebisch, Eva; Acker, Fabian; Fuhrmann, Stephan; Leng, Corinna; Welslau, Manfred; Chemnitz, Jens; Middeke, Jan-Moritz; Weber, Thomas; Holtick, Udo; Trappe, Ralf; Pfannes, Roald; Liersch, Ruediger; Spoer, Christian; Fuxius, Stefan; Gebauer, Niklas; Caillé, Léandra; Geer, Thomas; Koenecke, Christian; Keller, Ulrich; Claus, Rainer; Mougiakakos, Dimitrios; Mayer, Stephanie; Hüttmann, Andreas; Pott, Christiane; Trummer, Arne; Wulf, Gerald; Brunnberg, Uta; Bullinger, Lars; Hess, Georg; Mueller-Tidow, Carsten; Glass, Bertram; Lenz, Georg; Dreger, Peter; Dietrich, Sascha
    Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas
    In: Blood Advances Jg. 5 (2021) Nr. 13, S. 2707 - 2716
  • Kurch, Lars; Dührsen, Ulrich; Hüttmann, Andreas; Georgi, Thomas W.; Sabri, Osama; Kluge, Regine; Hasenclever, Dirk
    Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
    In: EJNMMI Research Jg. 11 (2021) Nr. 1, 90
  • Alig, Stefan; Macaulay, Charles W.; Kurtz, David M.; Dührsen, Ulrich; Hüttmann, Andreas; Schmitz, Christine; Jin, Michael C.; Sworder, Brian J.; Garofalo, Andrea; Shahrokh Esfahani, Mohammad; Nabet, Barzin Y.; Soo, Joanne; Scherer, Florian; Craig, Alexander F M; Casasnovas, Olivier; Westin, Jason R.; Gaidano, Gianluca; Rossi, Davide; Roschewski, Mark; Wilson, Wyndham H.; Meignan, Michel; Diehn, Maximilian; Alizadeh, Ash A.
    Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 23, S. 2605 - 2616
  • Schmitz, Christine; Rekowski, Jan; Müller, Stefan; Hertenstein, Bernd; Franzius, Christiane; Ganser, Arnold; Bengel, Frank M.; Kroschinsky, Frank; Kotzerke, Jörg; La Rosée, Paul; Freesmeyer, Martin; Hoeffkes, Heinz-Gert; Hertel, Andreas; Behringer, Dirk; Mesters, Rolf; Weckesser, Matthias; Mahlmann, Stefan; Haberkorn, Uwe; Martens, Uwe; Prange-Krex, Gabriele; Brenner, Winfried; Giagounidis, Aristoteles; Moeller, Regina; Runde, Volker; Sandmann, Matthias; Hautzel, Hubertus; Wilop, Stefan; Krohn, Thomas; Dürk, Heinz; Heike, Michael; Alashkar, Ferras; Brinkmann, Marcus; Trenn, Guido; Wacker, Dietmar; Kreisel-Büstgens, Christiane; Bernhard, Helga; Heil, Gerhard; Larisch, Rolf; Kurch, Lars; Jöckel, Karl-Heinz; Hoelzer, Dieter; Klapper, Wolfram; Boellaard, Ronald; Dührsen, Ulrich; Hüttmann, Andreas
    Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial
    In: Hematological Oncology (2020)
  • Schmitz, Christine; Hüttmann, Andreas; Müller, Stefan; Hanoun, Maher; Boellaard, Ronald; Brinkmann, Marcus; Jöckel, Karl-Heinz; Dührsen, Ulrich; Rekowski, Jan
    Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36] (European Journal of Cancer (2020) 124 (25–36), (S0959804919307555), (10.1016/j.ejca.2019.09.027))
    In: European Journal of Cancer (EJC) Jg. 136 (2020) S. 207 - 208
  • Schmitz, Christine; Hüttmann, Andreas; Müller, Stefan; Hanoun, Maher; Boellaard, Ronald; Brinkmann, Marcus; Jöckel, Karl-Heinz; Dührsen, Ulrich; Rekowski, Jan
    Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma : Post-hoc analysis from the PETAL trial
    In: European Journal of Cancer (EJC) Jg. 124 (2020) S. 25 - 36
  • Bröckelmann, Paul J.; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V.; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Mettler, Jasmin; Fuchs, Michael; Tresckow, Bastian von; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas
    Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma : The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial
    In: JAMA Oncology Jg. 6 (2020) Nr. 6, S. 872 - 880
  • Wagner, Bettina; Dührsen, Ulrich; Hüttmann, Andreas; Nückel, Holger; Michita, Rafael Tomoya; Rohn, Hana; Schramm, Sabine; Horn, Peter; Rebmann, Vera
    Genetic Variants of the NKG2C/HLA-E Receptor : Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma
    In: Cancers Jg. 12 (2020) Nr. 11, S. 3429
  • Schmitz, Christine; Rekowski, Jan; Müller, Stefan; Farsijani, Navid; Hertenstein, Bernd; Franzius, Christiane; von Verschuer, Ulla; La Rosée, Paul; Freesmeyer, Martin; Wilop, Stefan; Krohn, Thomas; Raghavachar, Aruna; Ganser, Arnold; Bengel, Frank M.; Prange-Krex, Gabriele; Kroschinsky, Frank; Kotzerke, Jörg; Giagounidis, Aristoteles; Dührsen, Ulrich; Hüttmann, Andreas
    Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy
    In: Cancer Medicine Jg. 99 (2020) Nr. 22, S. 8386 - 8396
  • Schmitz, Christine; Rekowski, Jan; Reinke, Sarah; Müller, Stefan; Hüttmann, Andreas; Klapper, Wolfram; Dührsen, Ulrich
    Metabolic tumor volume, cancer cell fraction, and prognosis–the case of T-cell/histiocyte-rich large B-cell lymphoma
    In: Leukemia and Lymphoma Jg. 61 (2020) Nr. 6, S. 1372 - 1379
  • Schmitz, Christine; Hüttmann, Andreas; Müller, Stefan; Hanoun, Maher; Boellaard, Ronald; Brinkmann, Marcus; Jöckel, Karl-Heinz; Dührsen, Ulrich; Rekowski, Jan
    Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination
    In: Data in Brief Jg. 28 (2020) 104976
  • Horwitz, Steven; O'Connor, Owen A.; Pro, Barbara; Illidge, Tim; Fanale, Michelle; Advani, Ranjana; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei; Hüttmann, Andreas; Savage, Kerry J.; Yuen, Sam; Iyer, Swaminathan; Zinzani, Pier Luigi; Hua, Zhaowei; Little, Meredith; Rao, Shangbang; Woolery, Joseph; Manley, Thomas; Trümper, Lorenz; Aboulafia, David; Alpdogan, Onder; Ando, Kiyoshi; Arcaini, Luca; Baldini, Luca; Bellam, Naresh; Yehuda, Dina Ben; Benedetti, Fabio; Borchman, Peter; Bordessoule, Dominique; Brice, Pauline; Briones, Javier; Caballero, Dolores; Carella, Angelo Michele; Chang, Hung; Cheong, June Weon; Cho, Seok-Goo; Choi, Ilseung; Choquet, Sylvain; Colita, Andrei; Congui, Angela Giovanna; D'amore, Francesco; Dang, Nam; Davison, Kelly; Guibert, Sophie de; Brown, Peter de Nully; Delwail, Vincent; Demeter, Judit; di Raimondo, Francesco; Do, Young Rok; Domingo, Eva; Douvas, Michael; Dreyling, Martin; Ernst, Thomas; Fay, Keith; Ferrero, Silvia Fernandez; Flinn, Ian Winchester; Forero-Torres, Andres; Fox, Christopher; Friedberg, Jonathan; Fukuhara, Noriko; Garcia-Marco, Jose; Cruz, Jorge Gayoso; Codina, Jose Gomez; Gressin, Remy; Grigg, Andrew; Gurion, Ronit; Haioun, Corinne; Hajek, Roman; Hanel, Mathias; Hatake, Kiyohiko; Hensen, Robert; Horowitz, Netanel; Ishizawa, Kenichi; Islas-Ohlmayer, Miguel; Jacobsen, Eric; Janakiram, Murali; Jurczak, Wojciech; Kaminski, Mark; Kato, Koji; Kirgner, Ilya; Kuo, Ching-Yuan; Lazaroiu, Mihaela Cornelia; Du, Katell Le; Lee, Jong-Seok; LeGouill, Steven; LaRosee, Paul; Levi, Itai; Link, Brian; Maisonneuve, Herve; Maruyama, Dai; Mayer, Jiri; McCarty, John; McKay, Pam; Minami, Yosuke; Mocikova, Heidi; Morra, Enrica; Munoz, Javier; Nagai, Hirokazu; Opat, Stephen; Pettengell, Ruth; Pezzutto, Antonio; Pfreundschuh, Michael; Pluta, Andrzej; Porcu, PierLuigi; Quach, Hang; Rambaldi, Alessandro; Renwick, William; Reyes, Ruben; Izquierdo, Antonia Rodriguez; Ruan, Jia; Rusconi, Chiara; Salles, Gilles; Santoro, Armando; Sarriera, Jose; Shibayama, Hirohiko; Suh, Cheolwon; Sureda, Anna; Tanimoto, Mitsune; Taniwaki, Masafumi; Tilly, Herve; Trneny, Marek; Tsukamoto, Norifumi; Vitolo, Umberto; Walewski, Jan; Weidmann, Eckhart; Wilhelm, Martin; Witzens-Harig, Mathias; Yacoub, Abdulraheem; Yamamoto, Kazuhito; Yoon, Sung-Soo; Yun, Hwan Jung; Zain, Jasmine
    Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2) : a global, double-blind, randomised, phase 3 trial
    In: Lancet Jg. 393 (2019) Nr. 10168, S. 229 - 240
  • Kurtz, David M.; Esfahani, Mohammad S.; Scherer, Florian; Soo, Joanne; Jin, Michael C.; Liu, Chih Long; Newman, Aaron M.; Dührsen, Ulrich; Hüttmann, Andreas; Casasnovas, Olivier; Westin, Jason R.; Ritgen, Matthais; Böttcher, Sebastian; Langerak, Anton W.; Roschewski, Mark; Wilson, Wyndham H.; Gaidano, Gianluca; Rossi, Davide; Bahlo, Jasmin; Hallek, Michael; Tibshirani, Robert; Diehn, Maximilian; Alizadeh, Ash A.
    Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction
    In: Cell Jg. 178 (2019) Nr. 3, S. 699 - 713.e19
  • Sakarou, Maria; Eisele, Lewin; Dührsen, Ulrich; Hüttmann, Andreas
    Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement
    In: European Journal of Haematology Jg. 102 (2019) Nr. 3, S. 241 - 250
  • Richter, Julia; Hüttmann, Andreas; Rekowski, Jan; Schmitz, Christine; Gärtner, Selina; Rosenwald, Andreas; Hansmann, Martin-Leo; Hartmann, Sylvia; Möller, Peter; Wacker, Hans-Heinrich; Feller, Alfred; Thorns, Christoph; Müller, Stefan; Dührsen, Ulrich; Klapper, Wolfram
    Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial : correlation with interim PET and outcome
    In: Blood Cancer Journal Jg. 9 (2019) Nr. 9, S. 67
  • Kurtz, David M.; Scherer, Florian; Jin, Michael; Soo, Joanne; Craig, Alexander F.M.; Esfahani, Mohammad Shahrokh; Chabon, Jacob J.; Stehr, Henning; Liu, Chih Long; Tibshirani, Robert; Maeda, Lauren S.; Gupta, Neel K.; Khodadoust, Michael S.; Advani, Ranjana H.; Newman, Aaron M.; Dührsen, Ulrich; Hüttmann, Andreas; Meignan, Michel; Casasnovas, Olivier; Westin, Jason R.; Roschewski, Mark; Wilson, Wyndham H.; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Reply to J. Wang et al
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 9, S. 755 - 758
  • Alashkar, Ferras; Vance, Colin; Herich-Terhürne, Dörte; Turki, Amin T.; Schmitz, Christine; Bommer, Martin; Hüttmann, Andreas; Dührsen, Ulrich; Vogel, Ulrich; Röth, Alexander
    Serologic response to meningococcal vaccination in patients with cold agglutinin disease (CAD) in the novel era of complement inhibition
    In: Vaccine Jg. 37 (2019) Nr. 44, S. 6682 - 6687
  • Hüttmann, Andreas; Rekowski, Jan; Müller, Stefan; Hertenstein, Bernd; Franzius, Christiane; Mesters, Rolf; Weckesser, Matthias; Kroschinsky, Frank; Kotzerke, Jörg; Ganser, Arnold; Bengel, Frank M.; La Rosée, Paul; Freesmeyer, Martin; Höffkes, Heinz-Gert; Hertel, Andreas; Behringer, Dirk; Prange-Krex, Gabriele; Griesshammer, Martin; Holzinger, Jens; Wilop, Stefan; Krohn, Thomas; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Schroers, Roland; Gaska, Tobias; Bernhard, Helga; Giagounidis, Aristoteles; Schütte, Jochen; Dienst, Ariane; Hautzel, Hubertus; Naumann, Ralph; Klein, Alfred; Hahn, Dennis; Pöpperl, Gabriele; Grube, Matthias; Marienhagen, Jörg; Schwarzer, Andreas; Kurch, Lars; Höhler, Thomas; Steiniger, Heike; Nückel, Holger; Südhoff, Thomas; Römer, Wolfgang; Brinkmann, Marcus; Ose, Claudia; Alashkar, Ferras; Schmitz, Christine; Dürig, Jan; Hoelzer, Dieter; Jöckel, Karl-Heinz; Klapper, Wolfram; Dührsen, Ulrich
    Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP : results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
    In: Annals of Hematology Jg. 98 (2019) Nr. 4, S. 897 - 907
  • Borchmann, Sven; Müller, Horst; Haverkamp, Heinz; Baues, Christian; Marková, Jana; Hüttmann, Andreas; Glunz, Axel; Fuchs, Michael; Borchmann, Peter; Engert, Andreas
    Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma : an analysis of the German Hodgkin Study Group (GHSG)
    In: Leukemia Jg. 33 (2019) Nr. 2, S. 439 - 446
  • Demirdas, Sedat; Hense, Jörg; Dührsen, Ulrich; Hüttmann, Andreas
    Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. 11,
  • Kurtz, David M.; Scherer, Florian; Jin, Michael C.; Soo, Joanne; Craig, Alexander F.M.; Esfahani, Mohammad Shahrokh; Chabon, Jacob J.; Stehr, Henning; Liu, Chih Long; Tibshirani, Robert; Maeda, Lauren S.; Gupta, Neel K.; Khodadoust, Michael S.; Advani, Ranjana H.; Levy, Ronald; Newman, Aaron M.; Dührsen, Ulrich; Hüttmann, Andreas; Meignan, Michel; Casasnovas, René-Olivier; Westin, Jason R.; Roschewski, Mark; Wilson, Wyndham H.; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Circulating tumor DNA measurements as early outcome predictors in diffuse large B-Cell lymphoma
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 28, S. 2845 - 2853
  • Röth, Alexander; Bommer, Martin; Hüttmann, Andreas; Herich-Terhürne, Dörte; Kuklik, Nils; Rekowski, Jan; Lenz, Veronika; Schrezenmeier, Hubert; Dührsen, Ulrich
    Eculizumab in cold agglutinin disease (DECADE) : an open-label, prospective, bicentric, nonrandomized phase 2 trial.
    In: Blood Advances Jg. 2 (2018) Nr. 19, S. 2543 - 2549
  • Pfeifer, Heike; Raum, Katharina; Markovic, Sandra; Nowak, Verena; Fey, Stephanie; Obländer, Julia; Pressler, Jovita; Böhm, Verena; Brüggemann, Monika; Wunderle, Lydia; Hüttmann, Andreas; Wäsch, Ralph; Beck, Joachim; Stelljes, Matthias; Viardot, Andreas; Lang, Fabian; Hoelzer, Dieter; Hofmann, Wolf-Karsten; Serve, Hubert; Weiss, Christel; Goekbuget, Nicola; Ottmann, Oliver G.; Nowak, Daniel
    Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation
    In: Blood Jg. 131 (2018) Nr. 13, S. 1464 - 1475
  • Zimmermann, Heiner; Babel, Nina; Dierickx, Daan; Morschhauser, Franck; Mollee, Peter; Zaucha, Jan M.; Dreyling, Martin H.; Dührsen, Ulrich; Reinke, Petra; Verhoef, Gregor; Subklewe, Marion; Hüttmann, Andreas; Tousseyn, Thomas; Bachy, Emmanuel; Hauser, Ingeborg A.; Tarella, Corrado; Van Den Neste, Eric; Gheysens, Olivier; Anagnostopoulos, Ioannis; Leblond, Veronique; Riess, Hanno; Choquet, Sylvain; Trappe, Ralf U.
    Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder : A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials
    In: Transplantation Jg. 102 (2018) Nr. 11, S. 1914 - 1923
  • Dührsen, Ulrich; Müller, Stefan; Hertenstein, Bernd; Thomssen, Henrike; Kotzerke, Jörg; Mesters, Rolf; Berdel, Wolfgang E.; Franzius, Christiane; Kroschinsky, Frank; Weckesser, Matthias; Kofahl-Krause, Dorothea; Bengel, Frank M.; Dürig, Jan; Matschke, Johannes; Schmitz, Christine; Pöppel, Thorsten; Ose, Claudia; Brinkmann, Marcus; La Rosée, Paul; Freesmeyer, Martin; Hertel, Andreas; Höffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Wilop, Stefan; Krohn, Thomas; Holzinger, Jens; Griesshammer, Martin; Giagounidis, Aristoteles; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Bernhard, Helga; Haberkorn, Uwe; Gaska, Tobias; Kurch, Lars; Van Assema, Daniëlle M.E.; Klapper, Wolfram; Hoelzer, Dieter; Geworski, Lilli; Jöckel, Karl-Heinz; Scherag, Andre; Bockisch, Andreas; Rekowski, Jan; Hüttmann, Andreas
    Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) : A Multicenter, Randomized Phase III Trial
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 20, S. 2024 - 2034
  • Dührsen, Ulrich; Müller, Stefan; Rekowski, Jan; Hüttmann, Andreas
    Reply to H.J.A adams et al and C. Gisselbrecht
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 32, S. 3273 - 3274
  • Wein, Frederik; Weniger, Marc; Höing, Benedikt; Arnolds, Judith; Hüttmann, Andreas; Hansmann, Martin-Leo; Hartmann, Sylvia; Küppers, Ralf
    Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma
    In: Cancer Immunology Research Jg. 5 (2017) Nr. 12, S. 1122 - 1132
  • Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, Max S; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; Kühnhardt, Dagmar; Ostermann, Helmut; Schmitz, Norbert; Hertenstein, Bernd; Aulitzky, Walter; Maschmeyer, Georg; Vieler, Tom; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Kuhnert, Georg; Diehl, Volker; Dietlein, Markus; Engert, Andreas
    PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18) : final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
    In: Lancet Jg. 390 (2017) Nr. 10114, S. 2790 - 2802
  • Cornely, Oliver A.; Leguay, Thibaut; Maertens, Johan; Vehreschild, Maria J.G.T.; Anagnostopoulos, Achilles; Castagnola, Carlo; Verga, Luisa; Rieger, Christina; Kondakci, Mustafa; Härter, Georg; Duarte, Rafael F.; Allione, Bernardino; Cordonnier, Catherine; Heussel, Claus Peter; Morrissey, C. Orla; Agrawal, Samir G.; Peter Donnelly, J.; Bresnik, Mark; Hawkins, Michael J.; Garner, Will; Gökbuget, Nicola; Jarchum, G.; Dictar, M.; Ramirez Borga, S.; Valledor, A.; Knoebl, P.; Greil, R.; Linkesch, W.; Sill, H.; De Prijck, B.; Sonet, A.; Theunissen, K.; Selleslag, D.; Vargas Schwarzbold, A.; Nucci, M.L.M.; Lopes de Castro Lobo, C.; Fogliatto, L.; Bonmati, C.; Turlure, P.; Herbrecht, R.; Thiebaut, A.; Michallet, M.; Egerer, G.; Silling, G.; Pfreundschuh, M.; Hasenkamp, J.; Kraemer, D.M.; Topp, M.; Heinz, W.; Junghanss, C.; Schaich, M.A.; Parmentier, S.; Roellig, C.; Beck, H.J.; Hüttmann, Andreas; Mousset, S.; Duenzinger, U.N.; Schwartz, S.; Ostermann, H.; Cornely, O.A.; Vehreschild, M.J.G.T.; Tsirigotis, P.; Matsouka, P.; Angelopoulou, M.K.; Karakantza, M.; Spyridonidis, A.; Kolomansky, A.; Moses, A.; Horowitz, N.; Rahav, G.; Aversa, F.; Velardi, A.; Pagano, L.; Gentile, G.; Gobbi, M.; Luppi, M.; Nosari, A.M.; Rambaldi, A.; Candoni, A.; Marbello, L.; Rossi, G.; Pogliani, E.; Moreira, I.; Nunes, A.; Botelho de Sousa, A.; Rubio Tejero, A.I.; Vallejo, C.; Vazquez, L.; Besalduch Vidal, J.; Gomez-Garcia de Soria, V.; Jurado Chacon, M.; González Campos, J.; Olavarria, E.; Barba, P.; de la Serna Torroba, J.; Heim, D.; Zimmerli, S.; Gerber, B.; Akova, M.; Bolaman, A.Z.; Tabak, F.; Akan, H.; Senol, E.
    Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
    In: Journal of Antimicrobial Chemotherapy Jg. 72 (2017) Nr. 8, S. 2359 - 2367
  • Trappe, Ralf U.; Dierickx, Daan; Zimmermann, Heiner; Morschhauser, Franck; Mollee, Peter; Zaucha, Jan M.; Dreyling, Martin H.; Dührsen, Ulrich; Reinke, Petra; Verhoef, Gregor; Subklewe, Marion; Hüttmann, Andreas; Tousseyn, Thomas; Salles, Gilles; Kliem, Volker; Hauser, Ingeborg A.; Tarella, Corrado; Van Neste, Eric Den; Gheysens, Olivier; Anagnostopoulos, Ioannis; Leblond, Veronique; Riess, Hanno; Choquet, Sylvain
    Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or r-chop consolidation in an international, prospective, multicenter Phase II trial
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 5, S. 536 - 543
  • Borchmann, P.; Goergen, H.; Kobe, C.; Fuchs, M.; Greil, R.; Zijlstra, J. M.; Hüttmann, Andreas; Markova, J.; Meissner, J.; Feuring-Buske, M.; Bentz, M.; Dierlamm, J.; Kuhnhardt, D.; Lohri, A.; Novak, U.; Eichenauer, D.; Eich, H.; Baues, C.; Stein, H.; Diehl, V.; Kuhnert, G.; Dietlein, M.; Engert, A.
    Treatment reduction in patients with advanced-stage Hodgkin Lymphoma and negative interim PET : Final results of the international, randomized phase 3 trial HD 18 by the German Hodkin Study Group
    In: Haematologica / The Hematology Journal Jg. 102 (2017) Nr. Suppl. 2, S. 24 - 25
  • Röllig, Christoph; Serve, Hubert; Hüttmann, Andreas; Noppeney, Richard; Müller-Tidow, Carsten; Krug, Utz; Baldus, Claudia D.; Brandts, Christian H.; Kunzmann, Volker; Einsele, Hermann; Krämer, Alwin; Schäfer-Eckart, Kerstin; Neubauer, Andreas; Burchert, Andreas; Giagounidis, Aristoteles; Krause, Stefan W.; Mackensen, Andreas; Aulitzky, Walter; Herbst, Regina; Hänel, Mathias; Kiani, Alexander; Frickhofen, Norbert; Kullmer, Johannes; Kaiser, Ulrich; Link, Hartmut; Geer, Thomas; Reichle, Albert; Junghanß, Christian; Repp, Roland; Heits, Frank; Dürk, Heinz; Hase, Jana; Klut, Ina-Maria; Illmer, Thomas; Bornhäuser, Martin; Schaich, Markus; Parmentier, Stefani; Görner, Martin; Thiede, Christian; von Bonin, Malte; Schetelig, Johannes; Kramer, Michael; Berdel, Wolfgang E.; Ehninger, Gerhard
    Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML) : a multicentre, phase 2, randomised controlled trial
    In: The lancet. Oncology Jg. 16 (2015) Nr. 16, S. 1691 - 1699
  • Hüttmann, Andreas; Müller, Stefan; Dührsen, Ulrich
    Outcome of aggressive non-Hodgkin lymphoma patients with a negative pretreatment positron emission tomography scan
    In: Leukemia and Lymphoma Jg. 56 (2015) Nr. 5, S. 1235 - 1235
  • Müller, Stefan; Hüttmann, Andreas; Rekowski, Jan; Geworski, Lilli; Pöppel, Thorsten; Bockisch, Andreas; Dührsen, Ulrich
    Positron Emission Tomography guided therapy of aggressive lympomas (PETAL) - the predictive value of quantitative PET
    In: Journal of Nuclear Medicine (JNM) Jg. 56 (2015) Nr. Suppl. 3, S. 210
  • Roellig, C.; Kramer, M.; Mueller-Tidow, C.; Hüttmann, Andreas; Noppeney, Richard; Kunzmann, V.; Baldus, C. D.; Brandts, C.; Kraemer, A.; Schaefer-Eckart, K.; Neubauer, A.; Krause, S. W.; Giagounidis, A.; Aulitzky, W.; Bornhaeuser, M.; Schaich, M.; Parmentier, S.; Thiede, C.; von Bonin, M.; Schetelig, J.; Serve, H.; Berdel, W. E.; Ehninger, G.
    Updated results from the soraml trial comparing sorafenib versus placebo in addition to standard therapy in younger patients with newly diagnosted acute myeloid leukemia
    In: Haematologica Jg. 100 (2015) Nr. Suppl. 1, S. 318 - 318
  • Hoelzer, Dieter; Walewski, Jan; Döhner, Hartmut; Viardot, Andreas; Hiddemann, Wolfgang; Spiekermann, Karsten; Serve, Hubert; Dührsen, Ulrich; Hüttmann, Andreas; Thiel, Eckhard; Dengler, Jolanta; Kneba, Michael; Schaich, Markus; Schmidt-Wolf, Ingo G H; Beck, Joachim; Hertenstein, Bernd; Reichle, Albrecht; Domanska-Czyz, Katarzyna; Fietkau, Rainer; Horst, Heinz-August; Rieder, Harald; Schwartz, Stefan; Burmeister, Thomas; Gökbuget, Nicola
    Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy : report of a large prospective multicenter trial
    In: Blood Jg. 124 (2014) Nr. 26, S. 3870 - 3879
  • Dührsen, Ulrich; Hüttmann, Andreas; Mueller, Stefan; Hertenstein, Bernd; Kotzerke, Joerg; Mesters, Rolf; Franzius, Christiane; Kroschinsky, Frank; Weckesser, Matthias; Franzke, Anke; Bengel, Frank; Dürig, Jan; Matschke, Johannes; Pöppel, Thorsten; Rekowski, Jan; Ose, Claudia; Brinkmann, Marcus; LaRosee, Paul; Freesmeyer, Martin; Hertel, Andreas; Hoeffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Wilop, Stefan; Krohn, Thomas; Fricke, Eva; Griesshammer, Martin; Giagounidis, Aristotele; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Brecht, Arne; Haberkorn, Uwe; Gaska, Tobias; Klapper, Wolfram; Hoelzer, Dieter; Jöckel, Karl-Heinz; Scherag, Andre; Bockisch, Andreas
    Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)
    In: Blood Jg. 124 (2014) Nr. 21, S. 391
  • Göbel, Maria; Eisele, Lewin; Möllmann, Michael; Hüttmann, Andreas; Johansson, Patricia; Scholtysik, Rene; Bergmann, Manuela; Busch, Raymonde; Döhner, Hartmut; Hallek, Michael; Seiler, Till; Stilgenbauer, Stephan; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
    In: PLoS ONE Jg. 23 (2013) Nr. 8, S. e72107
  • Hanoun, Maher; Eisele, Lewin; Suzuki, Masako; Greally, John M.; Hüttmann, Andreas; Aydin, Semra; Scholtysik, René; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia
    In: PLoS ONE Jg. 7 (2012) Nr. 12, S. e34347
  • Gökbuget, Nicola; Stanze, Daniel; Beck, Joachim D.; Diedrich, Helmut; Horst, Heinz A.; Hüttmann, Andreas; Kobbe, Guido; Kreuzer, Karl A.; Leimer, Lothar; Reichle, Albrecht; Schaich, Markus A.; Schwartz, Stefan; Serve, Hubert L.; Starck, Michael; Stelljes, Matthias; Stuhlmann, Reingard; Viardot, Andreas; Wendelin, Knut; Freund, Matthias R.F.; Hoelzer, Dieter F.; German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
    Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
    In: Blood Jg. 120 (2012) Nr. 10, S. 2032 - 2041
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, Ulrich; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, K.; Jöckel, Karl-Heinz; Moebus, Susanne; on behalf of the Heinz Nixdorf Recall Study Investigative Group
    Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany
    In: Annals of Hematology Jg. 91 (2012) Nr. 2, S. 243 - 248
  • Gobel, M.; Eisele, Lewin; Hüttmann, Andreas; Bergmann, M.; Busch, R.; Stilgenbauer, S.; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin plasma concentration is a novel independent prognostic marker in chronic lymphocytic leukemia
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 100
  • Sakarou, M.; Dührsen, Ulrich; Hüttmann, Andreas
    The GMALL-B-ALL/NHL protocol is an effective salvage treatment in relapsed and refractory aggressive B-cell non-Hodgkins lymphomas
    In: Onkologie Jg. 35 (2012) Nr. 6, S. 40
  • Gökbuget, Nicola; Basara, Nadezda; Baurmann, Herrad; Beck, Joachim; Brüggemann, Monika; Diedrich, Helmut; Güldenzoph, Björn; Hartung, Gernot; Horst, Heinz-August; Hüttmann, Andreas; Kobbe, Guido; Naumann, Ralph; Ratei, Richard; Reichle, Albrecht; Serve, Hubert; Stelljes, Matthias; Viardot, Andreas; Wattad, Mohammed; Hoelzer, Dieter
    High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation
    In: Blood Jg. 118 (2011) Nr. 13, S. 3504 - 3511
  • Röth, Alexander; Hüttmann, Andreas; Dührsen, U.; Philipp, Thomas;
    Inhibition of the Terminal Complement System Using Eculizumab for the Treatment of Cold Agglutinin Disease (CAD)
    184. Tagung der Rheinisch-Westfälischen Gesellschaft für Innere Medizin e.V.,
    In: Medizinische Klinik Jg. 105 (2010) Nr. 3, S. 213 - 214
  • Hüttmann, Andreas; Müller, Stefan; Jöckel, Karl-Heinz; Dührsen, Ulrich
    Pitfalls of interim positron emission tomography scanning in diffuse large B-cell lymphoma
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. 27, S. e488 - e489
  • Christoph, Sandra; Hüttmann, Andreas; Dührsen, Ulrich; Röth, Alexander
    Porphyria cutanea tarda
    In: British Journal of Haematology Jg. 148 (2010) Nr. 4, S. 493
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, U.; Führer, A.; Kieruzel, S.; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne;
    Prevalence of monoclonal gammopathy of undetermindes significance in a densley populated, highly industrialized area in Germany
    15th Congress of the European Hematology Association, Spain, Barcelona, June 10–13, 2010,
    In: Haematologica, the hematology journal Jg. 95 (2010) Nr. Suppl. 2, S. 394, 0949
  • Eisele, Lewin; Durig, J.; Hüttmann, Andreas; Dührsen, U.; Führer, A.; Kieruzel, S.; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne;
    Prevalence of monoclonal gammopathy of undetermined significance in a densely populated, highly industrialized area in Germany
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 95, V321
  • Dührsen, Ulrich; Hüttmann, Andreas; Dürig, Jan
    Prognostic Significance of Molecular Remission in Follicular Lymphoma
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. 30, S. e613
  • Hüttmann, Andreas; Klein-Hitpaß, Ludger; Thomale, Jürgen; Deenen, R.; Nückel, Holger; Ebeling, Peter; Führer, A.; Edelmann, J.; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status
    In: Leukemia Jg. 20 (2006) Nr. 10, S. 1774 - 1782
  • Nückel, Holger; Hüttmann, Andreas; Klein-Hitpaß, Ludger; Schroers, Roland; Führer, Anja; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia
    In: Leukemia & Lymphoma Jg. 47 (2006) Nr. 6, S. 1053 - 1061
  • Dürig, Jan; Nückel, Holger; Hüttmann, Andreas; Kruse, Elisabeth; Hölter, Tanja; Halfmeyer, Katja; Führer, Anja; Rudolph, Roland; Kalhori, Nasa; Nusch, Arnd; Deaglio, Silvia; Malavasi, Fabio; Möröy, Tarik; Klein-Hitpaß, Ludger; Dührsen, Ulrich
    Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia
    In: Blood Jg. 101 (2003) Nr. 7, S. 2748 - 2755
  • Dürig, Jan; Naschar, M.; Schmücker, U.; Renzing-Köhler, K.; Hölter, T.; Hüttmann, Andreas; Dührsen, Ulrich
    CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
    In: Leukemia Jg. 16 (2002) Nr. 1, S. 30 - 35
  • Abstracts

  • Zwezerijnen, G.; Bes, A.L.; Heymans, M.W.; Dührsen, Ulrich; Hüttmann, Andreas; Hanoun, C.
    Combining Baseline and End of Treatment Quantitative PET Parameters to Improve Progression-Free Survival Prediction in DLBCL
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. S47 - S48
  • Borchmann, Peter; Moccia, Alden; Greil, Richard; Schneider, Gundolf; Hertzberg, Mark S.; Schaub, Valdete; Hüttmann, Andreas; Keil, Felix; Schaub, Valdete; Hänel, Mathias; Novak, Urban; Meissner, Julia; Zimmermann, Andreas; Mathas, Stephan; Zijlstra, Josée M; Fosså, Alexander; Viardot, Andreas; Hertenstein, Bernd; Martin, Sonja; Giri, Pratyush; Kamper, Peter; Molin, Daniel L.; Kreissl, Stefanie; Ferdinandus, Justin; Fuchs, Michael; Rosenwald, Andreas; Klapper, Wolfram; Eich, Hans; Baues, Christian; Hallek, Michael; Dietlein, Markus; Kobe, Carsten; Diehl, Volker
    Comprehensive Analysis of Treatment Related Morbidity and Progression-Free Survival in the GHSG Phase III HD21 Trial
    In: Blood Jg. 142 (2023) Nr. Supplement 1: Annual Meeting Abstracts (65th ASH Annual Meeting and Exposition, 9-12 Dezember 2023, San Diego), S. 3057 - 3057
  • Topp, M.; Hüttmann, Andreas; Kimmich, C.; Hänel, M.; Strickland, D.; Weber, T.;
    Global Phase 2 Basket Trial of Nanatinostat in Combination with Valganciclovir in Patients with EBV-Positive (EBV plus ) Relapsed/Refractory Lymphomas (NAVAL-1, trial in progress)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 186 - 187
  • Denker, S.; Bittner, A.; Frick, M.; Hüttmann, Andreas; Dührig, J.; Schmitt, C. A.; et al.;
    Ibrutinib + bortezomib + R-CHOP for higher-risk DLBCL : Efficacy, feasibility and molecular predictors
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 24
  • Hoffmann, Christian; Ringbaek, Toke; Garcia, Alina Santiago; Flühs, Andrea; Heintz, Martin; Lübcke, Wolfgang; Indenkämpen, Frank; Sauerwein, Wolfgang; Moliavi, Sourour; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Eckstein, Anja; Johansson, Patricia; Hüttmann, Andreas; Stuschke, Martin; Guberina, Maja
    Linsenschonende Elektronenbestrahlung bei konjunktivalen Non-Hodgkin Lymphomen : Monozentrische Langzeitdaten zur Efektivität und Nebenwirkungen
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S106
  • Ferdinandus, J.; Moccia, A.; Greil, R.; Hüttmann, Andreas; Borchmann, P.; et al.; ; German Hodgkin Study Group (GHSG)
    Treatment related organ toxicities at one year follow-up in patients with advanced stage classical Hodgkin Lymphoma : results from the randomized phase III HD21 trial by the German Hodgkin Study Group
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 111
  • Boegeholz, Jan; Alig, Stefan K.; Sworder, Brian; Schroers-Martin, Joseph; Macaulay, Charles; Craig, Alexander F.M.; Duehrsen, Ulrich; Hüttmann, Andreas; Westin, Jason; Cherng, Hua-Jay J.; Miklos, David B.; Frank, Matthew J; Diehn, Maximilian; Kurtz, David M.; Alizadeh, Ash A.
    Clonal Hematopoiesis Driven By Recurrent Somatic Mutations but Not with Recurrent Copy Number Alterations Is Associated with Inferior Outcomes in DLBCL after Induction Chemotherapy, but Not CAR19 Therapy
    In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans, S. 8609 - 8610
  • Sworder, Brian; Kurtz, David M.; Alig, Stefan K.; Frank, Matthew J; Shukla, Navika D.; Garofalo, Andrea; Macaulay, Charles; Shahrokh Esfahani, Mohammad; Olsen, Mari; Hamilton, James; Hosoya, Hitomi; Hamilton, Mark P; Spiegel, Jay Y.; Baird, John H.; Carleton, Mia; Craig, Alexander F.M.; Younes, Sheren F.; Sahaf, Bita; Sheybani, Natasha; Schroers-Martin, Joseph; Liu, Chih Long; Oak, Jean S; Jin, Michael C.; Beygi, Sara; Hüttmann, Andreas; Hanoun, Christine; Dührsen, Ulrich; Westin, Jason; Khodadoust, Michael S.; Natkunam, Yasodha; Majzner, Robbie G.; Mackall, Crystal L.; Diehn, Maximilian; Miklos, David B.; Alizadeh, Ash A.;
    Determinants of Resistance to Engineered T-Cell Therapies Targeting CD19 in Large B-Cell Lymphomas
    64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,
    In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 1301 - 1303
  • Eertink, Jakoba J.; Zwezerijnen, Gerben JC; Heymans, Martijn W.; Pieplenbosch, Simone; Wiegers, Sanne E.; Dührsen, Ulrich; Hüttmann, Andreas; Kurch, Lars; Hanoun, Christine; Lugtenburg, Pieternella; Barrington, Sally F.; Mikhaeel, George; Ceriani, Luca; Zucca, Emanuele; Czibor, Sandor; Györke, Tamás; Chamuleau, Martine E.D.; Hoekstra, Otto S.; de Vet, Henrica C.W; Boellaard, Ronald; Zijlstra, Josée M.;
    External Validation Shows That Baseline PET Radiomics Outperform the IPI Risk Score for Prediction of Outcome in DLBCL
    64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH): DEC 10-13, 2022; New Orleans, USA,
    In: Blood Jg. 140 (2022) Nr. Supplement 1, S. 777 - 778
  • Hüttmann, Andreas;
    PET/CT bei indolenten Lymphoma : wann und warum?
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 147
  • Van Dijk, Erik; Janssen, Jurriaan; Mendeville, Matias; Los-De Vries, G. Tjitske; Roemer, Margaretha GM; Stathi, Phylicia; Richter, Julia; Kim, Yong Soo; Klapper, Wolfram; Dührsen, Ulrich; Hüttmann, Andreas; Lugtenburg, P. J; Zijlstra, Josée M.; Kersten, Marie Jose; de Jong, Daphne; Chamuleau, Martine E.D.; Ylstra, Bauke;
    The Position of MYC Rearrangements in the Genomic Landscape of Diffuse Large B-Cell Lymphoma
    64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,
    In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 9261 - 9263
  • Borchmann, Peter; Moccia, Alden; Greil, Richard; Hertzberg, Mark; Schaub, Valdete; Hüttmann, Andreas; Keil, Felix; Dierlamm, Judith; Haenel, Mathias; Novak, Urban; Meissner, Julia; Zimmermann, Andreas; Mathas, Stephan; Zijlstra, Josée M.; Fosså, Alexander; Viardot, Andreas; Hertenstein, Bernd; Martin, Sonja; Giri, Pratyush; Kamper, Peter; Molin, Daniel; Kreissl, Stefanie; Fuchs, Michael; Schneider, Gundolf; Rosenwald, Andreas; Klapper, Wolfram; Eich, Hans; Baues, Christian; Hallek, Michael; Dietlein, Markus; Kobe, Carsten; Diehl, Volker; Engert, Andreas;
    Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma : Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group
    64th Annual Meeting and Exposition of the American Society of Hematology, December 10 - 13, 2022, New Orleans,
    In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 771 - 773
  • Eertink, Jakoba J; Zwezerijnen, Gerben J.C; Wiegers, Sanne E; Chamuleau, Martine E.D; Lugtenburg, Pieternella; De Jong, Daphne; Ylstra, Bauke; Mendeville, Matias; Dührsen, Ulrich; Hüttmann, Andreas; Schmitz, Christine; Richter, Julia; Klapper, Wolfram; Hoekstra, Otto S; de Vet, Henrica C.W; Boellaard, Ronald; Zijlstra, Josée M;
    Combining PET Radiomic Features with MYC Gene Rearrangement Results in High Prediction of Outcome in Diffuse Large B-Cell Lymphoma
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 451 - 453
  • Hüttmann, Andreas; et al, .;
    Echelon-2 (NCT01777152), a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin plus CHP VS CHOP in Previously Untreated Patients with CD30-Positive Peripheral T-Cell Lymphoma : 5-Year Results
    48th Congress of the Italian Society of Hematology, 24-27 October 2021, Milan, Italy,
    In: Haematologica / The Hematology Journal Jg. 106 (2021) Nr. 10, S3: 48th Congress of the Italian Society of Hematology, 24-27 October 2021, S. 3
  • Momotow, Jesko; Bühnen, Ina; Trautmann-Grill, Karolin; Kobbe, Guido; Wilhelm, Martin; Heinrich, Bernhard; Gaska, Tobias; Forstbauer, Helmut; Schmidt, Burkhard; Hüttmann, Andreas; Heil, Gerhard; Kraemer, Doris M.; Krüger, William Hermann; Zeremski, Vanja; Grobe, Norbert; Jentsch-Ulrich, Kathleen; Fuchs, Michael; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas; Bröckelmann, Paul J.;
    Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma : A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 4533 - 4535
  • Kurtz, David Matthew; Chabon, Jacob J.; Soo, Joanne; Co Ting Keh, Lyron; Alig, Stefan; Schultz, Andre; Jin, Michael C.; Scherer, Florian; Craig, Alexander F.M.; Liu, Chih Long; Duehrsen, Ulrich; Hüttmann, Andreas; Casasnovas, René-Olivier; Westin, Jason; Roschewski, Mark J.; Wilson, Wyndham Hopkins; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.
    Phased variants improve DLBCL minimal residual disease detection at the end of therapy
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 7565 - 7565
  • Fischer, Luca; Jiang, Linmiao; Bittenbring, Joerg; Hübel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Jürgen; Glass, Bertram; Hüttmann, Andreas; Schaefer-Eckart, Kerstin; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin H.; Hoster, Eva;
    The Addition of Rituximab to Cyclophosphamide, Doxorubicine, Vincristine and Prednisone (CHOP) Prolongs Overall Survival in Previously Untreated Mantle Cell Lymphoma : A Long Term Pooled Trials Analysis
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3551 - 3553
  • Iyer, Swaminathan; Trümper, Lorenz; O’Connor, Owen A.; Pro, Barbara; Illidge, Tim; Advani, Ranjana; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Menne, Tobias; Belada, David; Illès, Árpád; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei; Hüttmann, Andreas; Savage, Kerry J.; Yuen, Sam; Zinzani, Pier Luigi; Miao, Harry; Bunn, Veronica; Fenton, Keenan; Fanale, Michelle; Puhlmann, Markus; Horwitz, Steven;
    The ECHELON-2 Trial : 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
    Society of Hematologic Oncology 9th Annual Meeting ; September 8–11, 2021, Houston, Texas, USA & Virtual Venue,
    In: Clinical Lymphoma, Myeloma & Leukemia Jg. 21 (2021) Nr. Suppl. 1, S. S411
  • Momotow, J.; Sasse, S.; Plütschow, A.; Hüttmann, Andreas; Basara, N.; Könecke, C.; Martin, S.; Bentz, M.; Große-Thie, C.; Thorspecken, S.; Wit, M. de; Kobe, C.; Dietlein, M.; Tresckow, Bastian von; Fuchs, M.; Borchmann, P.; Engert, A.;
    AFM13 in patients with relapsed or refractory Hodgkin Lymphoma : Final results of an open-label, randomized, multicenter phase II trial
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 89
  • Mikhaeel, N.; Heymans, M. W.; de Vet, H. C. W.; Eertink, J. J.; Boellaard, R.; Dührsen, Ulrich; Hüttmann, Andreas; Schmitz, Christine; Ceriani, L.; Zucca, E.; Hoekstra, O. S.; Zijlstra, J. M.; Barrington, S.;
    Characteristics of the relationship between MTV and survival in diffuse large B-cell lymphoma : A PETRA consortium study
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S357
  • Hüttmann, Andreas;
    Classical Hodgkin-Lymphoma : PET-guided therapy and implementation of new substances from a global perspective
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 4
  • Kaddu-Mulindwa, D.; Altmann, B.; Held, G.; Angel, S.; Stilgenbauer, S.; Thurner, L.; Bewarder, Moritz; Schwier, M.; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Pöschel, Viola; Hellwig, Dirk;
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL > 60 trials
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 55 - 56
  • Alashkar, Ferras; Carpinteiro, Alexander; Bauer, Sebastian; Hüttmann, Andreas; Dührsen, Ulrich; Reinhardt, Hans Christian; Röth, Alexander;
    Think twice : Anemia of chronic disease (ACD) due to angiomatoid fibrous histiocytoma (AFH)
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 181
  • Wermann, W. K.; Schwartz, S.; Fiedler, W.; Kayser, S.; Hüttmann, Andreas; Alakel, N.; Bargou, R.; Faul, C.; Heidenreich, D.; Jung, W.; Martin, S.; Subklewe, M.; Topp, M.; Viardot, A.; Vucinic, V.; Wäsch, R.; Brüggemann, M.; Gökbuget, N.;
    Interim results of a multicenter, single-arm study to assess Blinatumomab in adult patients (pts) with minimal residual disease (MRD) of B-precursor (BCP) acute lymphoblastic leukemia (GMALL-MOLACT1-BLINA)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 174 - 175
  • Bröckelmann, Paul J; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Fuchs, Michael; von Tresckow, Bastian; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas;
    Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)
    61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,
    In: Blood Jg. 134 (2019) Nr. Supplement_1: 61st ASH Annual Meeting, S. 236 - 236
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Ziepert, Marita; Menhart, Karin; Grosse, Jirka; Angel, Stephanie; Stilgenbauer, Stephan; Pfreundschuh, Michael; Herrmann, Ken; Duehrsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Hellwig, Dirk; Poeschel, Viola;
    Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma
    Konferenz 61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,
    In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 2892 - 2892
  • Alig, Stefan; Macaulay, Charles; Kurtz, David M.; Dührsen, Ulrich; Hüttmann, Andreas; Jin, Michael C.; Sworder, Brian; Garofalo, Andrea; Esfahani, Mohammad Shahrokh; Soo, Joanne; Scherer, Florian; Craig, Alexander; Casasnovas, Olivier; Westin, Jason R.; Gaidano, Gianluca; Rossi, Davide; Diehn, Maximilian; Alizadeh, Ash A.;
    Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma
    61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,
    In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 491 - 491
  • Trümper, L.; O’Connor, O. A.; Pro, B.; Illidge, T. M.; Advani, R. H.; Bartlett, N. L.; Haaber Christensen, J.; Morschhauser, F.; Domingo- Domenech, E.; Rossi, G.; Kim, W. S.; Feldman, T. A.; Lennard, A.; Belada, D.; Illés, Á.; Tobinai, K.; Tsukasaki, K.; Yeh, S.-P.; Shustov, A. R.; Hüttmann, Andreas; Savage, K. J.; Yuen, S.; Iyer, S.; Zinzani, P. L.; Hua, Z.; Little, M.; Rao, S.; Woolery, J.; Manley, T.; Horwitz, S. M.;
    The ECHELON-2 trial : Results of a randomised, double-blind, active-controlled phase 3 study of brentuximab vedotin and CHP (A+CHP) vs CHOP in the frontline treatment of patients (pts) with CD30⁺ peripheral T-cell lymphomas (PTCLs)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 23
  • Eertink, Jakoba J; Burggraaff, Coreline N; Heymans, Martijn W; Barrington, Sally F; Mikhaeel, George; Dührsen, Ulrich; Hüttmann, Andreas; Ceriani, Luca; Zucca, Emanuele; Carr, Robert; Györke, Tamás; Fanti, Stefano; Higley, Howard R; Knopp, Michael V; Schöder, Heiko; Loft, Annika; Hutchings, Martin; Kostakoglu, Lale; Lugtenburg, Pieternella; Wiegers, Sanne E; Pieplenbosch, Simone; Boellaard, Ronald; Hoekstra, Otto S; Zijlstra, Josée M; de Vet, Henrica C.W.;
    The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma : An Individual Patient Data Meta-Analysis By the Petra Consortium
    61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,
    In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 487
  • von Tresckow, Bastian; Hüttmann, Andreas; Vucinic, Vladan; Mueller, Horst; Plütschow, Annette; Viardot, Andreas; Topp, Max S.; Kobe, Carsten; Böll, Boris; Eichenauer, Dennis A.; Sasse, Stephanie; Haverkamp, Heinz; Fuchs, Michael; Engert, Andreas; Borchmann, Peter;
    Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma : A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i)
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 2912 - 2912
  • Rekowski, Jan; Hüttmann, Andreas; Schmitz, Christine; Müller, Stefan; Jöckel, Karl-Heinz; Duehrsen, Ulrich;
    Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial : Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 1696 - 1696
  • Schroers-Martin, Joseph G; Garofalo, Andrea; Soo, Joanne; Jin, Michael C.; Kurtz, David M.; Buedts, Lieselot; Dührsen, Ulrich; Hüttmann, Andreas; Cottereau, Anne Ségolène; Meignan, Michel; Casasnovas, Olivier; Westin, Jason R.; Gaidano, Gianluca; Rossi, Davide; Roschewski, Mark; Wilson, Wyndham H.; Advani, Ranjana H; Vandenberghe, Peter; Diehn, Maximilian; Khush, Kiran; Alizadeh, Ash A.;
    Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing
    Konferenz 60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 2861 - 2861
  • Richter, Julia; Hüttmann, Andreas; Rekowski, Jan; Schmitz, Christine; Gärtner, Selina; Ose, Claudia; Rosenwald, Andreas; Hansmann, Martin-Leo; Hartmann, Sylvia; Moeller, Peter; Wacker, Hans-Heinrich; Feller, Alfred; Thorns, Christoph; Müller, Stefan; Duehrsen, Ulrich; Klapper, Wolfram
    Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial
    In: Blood Jg. 132 (2018) Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 4188 - 4188
  • Jin, Michael C.; Schroers-Martin, Joseph G; Kurtz, David M.; Buedts, Lieselot; Esfahani, Mohammad S; Macaulay, Charles; Sworder, Brian; Soo, Joanne; Glover, Cynthia; Roschewski, Mark; Wilson, Wyndham H.; Dührsen, Ulrich; Hüttmann, Andreas; Rossi, Davide; Gaidano, Gianluca; Westin, Jason R.; Maeda, Lauren S.; Advani, Ranjana H; Vandenberghe, Peter; Diehn, Maximilian; Alizadeh, Arash A.;
    Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 2838 - 2838
  • Hess, Georg; Hüttmann, Andreas; Meissner, Julia; Marks, Reinhard; Dreyling, Martin; Keller, Ulrich; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Deuster, Oliver; van Oordt, Christina; Theobald, Matthias; Lenz, Georg;
    Obinutuzumab (GA101) in Combination with Pixantrone for the Treatment of Patients with Relapsed Aggressive B-Cell Lymphoma : Â a Phase II Trial (GOAL)
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 1678 - 1678
  • Koeppen, Susanne; Alashkar, Ferras; Stolte, B.; Hüttmann, Andreas;
    Predominantly motor polyneuropathy following brentuximab vedotin
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 319
  • Horwitz, Steven M.; O'Connor, Owen A.; Pro, Barbara; Illidge, Tim M.; Fanale, Michelle A.; Advani, Ranjana H; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana A.; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei R.; Hüttmann, Andreas; Savage, Kerry J; Yuen, Sam; Zinzani, Pier Luigi; Hua, Zhaowei; Little, Meredith; Rao, Shangbang; Woolery, Joseph; Manley, Thomas; Trümper, Lorenz;
    The ECHELON-2 Trial : Results of a Randomized, Double-Blind, Active-Controlled Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 997 - 997
  • Röllig, C.; Serve, H.; Hüttmann, Andreas; Noppeney, Richard; Müller-Tidow, Carsten; Krug, U.; Baldus, C. D.; Brandts, C. H.; Kunzmann, V.; Einsele, H.; Krämer, A.; Schäfer-Eckart, K.; Neubauer, A.; Burchert, A.; Giagounidis, A.; Krause, S. W.; Mackensen, A.; Aulitzky, W.; Herbst, R.; Hänel, M.; Kiani, A.; Frickhofen, N.; Kullmer, J.; Kaiser, U.; Link, H.; Geer, T.; Reichle, A.; Junghanß, C.; Bornhäuser, M.; Schaich, M.; Thiede, C.; Schetelig, J.; Kramer, M.; Berdel, W. E.; Ehninger, G.; Studienallianz Leukämie (SAL);
    The addition of sorafenib to standard AML treatment results in a substantial reduction in relapse risk and improved survival : Updated results from long-term follow-up of the randomized-controlled SORAML trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 9
  • Dührsen, Ulrich; Hüttmann, Andreas; Muller, S.; Hertenstein, B.; Thomssen, H.; Kotzerke, J.; Mesters, R.; Berdel, W. E.; Franzius, C.; Kroschinsky, F.; Weckesser, M.; Kofahl-Krause, D.; Bengel, F. M.; Dürig, Jan; Matschke, Johannes; Pöppel, Thorsten; Ose, C.; Brinkmann, M.; La Rosee, P.; Freesmeyer, M.; Hertel, A.; Hoffkes, H. G.; Behringer, D.; Prange-Krex, G.; Wilop, S.; Krohn, T.; Holzinger, J.; Griesshammer, M.; Giagounidis, A.; Raghavachar, A.; Maschmeyer, G.; Brink, I.; Bernhard, H.; Haberkorn, U.; Gaska, T.; Kurch, L.; Klapper, W.; Hoelzer, D.; Geworski, L.; Jöckel, Karl-Heinz; Scherag, Andre; Rekowski, J.; Bockisch, Andreas; PETAL Trial Investigators
    Positron-emission tomography-guided therapy of aggressive non-Hodgkin lymphomas -final results of the PETAL trial
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 202 - 203
  • Röth, Alexander; Hüttmann, Andreas; Dührsen, Ulrich;
    DECADE Trial : Inhibition of theterminal complement system using the anti-C5 antibody eculizumab for the treatment of cold agglutinin disease (CAD)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 112
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, Ulrich; Führer, Anja; Kieruzel, Sabrina; Assert, Roland; Bokhof, Beate; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne
    Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In Germany
    In: Blood Jg. 116 (2010) Nr. 21, 4037